Allergan plc

AGN

$193.02

+0.0% (1 year change)

Avg closing price

Price range

Market Cap

$63.4 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

Revenue

$3.6 Billion

Total revenue in the last quarter.

Net Income

$378 Million

Net income is all revenues minus all expenses including taxes and interest in the last quarter.

Earnings per Share

$-7.58

Earnings per share is the amount of net income that is attributed to each single share outstanding.

Dividends per Share

$2.96 (1.53%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Price-Earnings Ratio

-25.46x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

EBIT

$-72.5 Million

Earnings before interest expenses and taxes in the last quarter.

Employees

17,400

The number of full time employees.

Revenue & Earnings

Balance Sheet

Allergan plc

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

News

AbbVie Inc. Completes Acquisition of Allergan plc

AbbVie Inc. Completes Acquisition of Allergan plc

DUBLIN, May 8, 2020 /PRNewswire/ -- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT ...

PR Newswire PR Newswire, 6 months ago
COVID-19 Impact and Recovery Analysis- Global Chemical Peel Market 2020-2024 | Evolving Opportunities with Allergan Plc and Bausch Health Companies Inc. | Technavio

COVID-19 Impact and Recovery Analysis- Global Chemical Peel Market 2020-2024 | Evolving Opportunities with Allergan Plc and Bausch Health Companies Inc. | Technavio

LONDON--(BUSINESS WIRE)-- #ChemicalPeelMarket--The chemical peel market is poised to grow by 62.78 mn during 2020-2024, according to Technavio

Business Wire Business Wire, 6 months ago
The Allergan Foundation Doubles its COVID-19 Response Donations to $4.0 Million

The Allergan Foundation Doubles its COVID-19 Response Donations to $4.0 Million

DUBLIN, May 7, 2020 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that The Allergan Foundation has fast-tracked another $2 million dollars in charitable grants for community organization...

PR Newswire PR Newswire, 6 months ago